News

You heard it here first.

 
 
 

Our news

Bringing you the latest!

All news

MedinCell partners to address the untapped financial potential in Animal Health

Investors

28 August 2019

Third long-acting injectable antipsychotic using MedinCell’s technology enters preclinical development

Corporate

9 July 2019

MedinCell wins the #LetsgoFrance 2019 trophy in the category “France, a model of sustainable economy” (in French)

Corporate

5 April 2019

MedinCell demonstrates in vivo the efficacy of the first injectable combining surgical anesthesia and 3 days opioid free postoperative pain management

Corporate

11 March 2019

MedinCell receives 2nd part of the grant from the Bill & Melinda Gates Foundation

Corporate

24 January 2019

 
 

Press

Communication leader
MedinCell
David Heuzé
david.heuze@medincell.com
+33 (0)6 83 25 21 86

Media
NewCap
Nicolas Merigeau
medincell@newcap.eu
+33 (0)1 44 71 94 94

Investors

Investors website

Investor Relations
NewCap
Louis-Victor Delouvrier /
Alexia Faure

medincell@newcap.eu
+33 (0)1 44 71 94 94

CONTACT

  • This field is for validation purposes and should be left unchanged.